Evidence map›Paper›PMID 26045752›Full record

ArticleInternational journal of clinical and experimental pathology2015

MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.

Yong Shang, Li-Qing Wang, Quan-Yi Guo, Tu-Long Shi

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. miRNA signatures in childhood sarcomas and their clinical implications.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. MicroRNA-21 promotes endometrial carcinoma proliferation and invasion by targeting PTEN.International journal of clinical and experimental pathology · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Yong ShangDepartment of Orthopaedics, Air Force General Hospital of PLA Beijing 100142, People's Republic of China.
Li-Qing WangDepartment of Chronic Diseases, Haidian Center For Disease Control and Prevention Beijing 100142, People's Republic of China.
Quan-Yi GuoInstitute of Orthopaedics, Chinese PLA General Hospital Beijing 100142, People's Republic of China.
Tu-Long ShiDepartment of Orthopaedics, Air Force General Hospital of PLA Beijing 100142, People's Republic of China.
Air Force General Hospital PLA · CNChinese PLA General Hospital · CNNational Center for Chronic and Noncommunicable Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are endogenous, non-coding, small RNAs, which play a critical role in regulating varieties of the biological and pathologic processes. MiR-196a has been reported to take part in tumorigenic progression of osteosarcoma (OS). However, the effects of miR-196a on OS are still unclear. The objective of this study is to investigate the molecular mechanism of miR-196a in osteosarcoma cells. In the present study, the expression of miR-196a in OS cell lines was detected by real-time PCR. We found that the expression level of miR-196a was markedly up-regulated in osteosarcoma cell lines compared with normal osteoblastic cells. Then, the miR-196a mimic was transiently transfected into MG63 and U2OS cells using Lipofectamine™ 2000 reagent. Subsequently, the MTT and Brdu-ELISA results showed that up-regulation of miR-196a promoted the cell viability and proliferation. Our results also showed that miR-196a mimic accelerated cell cycle progression of MG63 and U2OS cells by down regulation of p21 and p27, and upregulation of cyclin D1. In addition, overexpression of miR-196a suppressed apoptosis of MG63 and U2OS cells due to increasing BCL2L2 and MCL-1 expressions, and then inactivating caspase-3. Eventually, the effect of miR-196a mimic on the PTEN/phosphoinositide 3-kinase (PI3K)/Akt signaling pathway was explored by Western blot. From our results, transfection of miR-196a decreased the expression of PTEN and increased the phosphorylation of PI3K and Akt. Taken together, miR-196a should be an oncogene in osteosarcoma. The possible mechanism was that overexpression of miR-196a promoted proliferation of MG63 and U2OS cells by modulating the PTEN/PI3K/Akt signaling pathway.

Indexed as

ApoptosisCell ProliferationApoptosis Regulatory ProteinsBone NeoplasmsCell Cycle ProteinsCell Line, TumorForkhead Box Protein O1Forkhead Transcription FactorsGene Expression Regulation, NeoplasticHumansMicroRNAsOsteosarcomaPhosphatidylinositol 3-KinasePhosphorylationProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseApoptosis Regulatory ProteinsCell Cycle ProteinsForkhead Box Protein O1Forkhead Transcription FactorsFOXO1 protein, humanMicroRNAsMIRN196 microRNA, humanPhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanapoptosiscell cycleMicroRNA-196aosteosarcomaproliferationPTEN/PI3K/Akt signaling pathway

Identifiers

PMID26045752
PMCPMC4440061
OpenAlexW2402849622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.